Wellington Shields Capital Management, LLC Precigen, Inc. Transaction History

Wellington Shields Capital Management, LLC

$558 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 05, 2020	SELL	$2.16 - $5.46 $43,200 - $109,200	-20,000 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$1.46 - $7.19 $29,200 - $143,800	20,000 New	20,000 $68,000

Others Institutions Holding PGEN

# of Institutions

144

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

Third Security, LLC

83.5M
Shares

$65.9 Million
73.5% of portfolio
Patient Capital Management, LLC Baltimore, MD

17.9M
Shares

$14.2 Million
0.92% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

10.9M
Shares

$8.58 Million
0.02% of portfolio
Black Rock Inc. New York, NY

10.2M
Shares

$8.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.33M
Shares

$6.58 Million
0.0% of portfolio

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $164M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.

Account